– USA, RI – Astro-Med, Inc., d/b/a AstroNova (NASDAQ: ALOT) announced that April Ondis has been elected to its Board of Directors.
Ms. Ondis, 41, has been the Digital Content Marketing Manager at Crossref, a not-for-profit membership organization for scholarly publishing working to make content easy to identify, cite, link, and assess, since August 2015. Previously, Ms. Ondis was Senior Manager, Applied Marketing for QuickLabel Systems, an AstroNova business unit. She originally joined AstroNova in 1998, and has held various positions within the company. Ms. Ondis is also the daughter of the late Albert W. Ondis, the company’s founder, and is the beneficial owner of 13.8% of the company’s common stock as of October 31, 2015. Ms. Ondis holds a Bachelor of Arts from Connecticut College, a Master of Science in Integrated Marketing Communications, Marketing and Advertising from West Virginia University, and a Master of Business Administration from St. Joseph’s College of Maine.
“April’s extensive knowledge of the company’s markets will be a valuable addition and we are very pleased to welcome April to the AstroNova Board,” said Gregory A. Woods, President and Chief Executive Officer.
About AstroNova
Astro-Med, Inc., d/b/a AstroNova, is a global leader in data visualization technology that delivers accuracy, efficiency, speed, and performance across a range of end-user markets. The Company’s products include color label printers and consumables sold under the QuickLabel brand, ruggedized printers and networking products for aerospace and defense applications, as well as test & measurement products sold under the AstroNova brand. Astro-Med, Inc. is a member of the Russell Microcap Index.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
